Strs Ohio Sells 11,700 Shares of Maximus, Inc. (NYSE:MMS)

Strs Ohio lowered its stake in shares of Maximus, Inc. (NYSE:MMS) by 63.6% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 6,700 shares of the health services provider’s stock after selling 11,700 shares during the quarter. Strs Ohio’s holdings in Maximus were worth $561,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in MMS. FMR LLC grew its position in Maximus by 6.4% during the third quarter. FMR LLC now owns 8,588,189 shares of the health services provider’s stock valued at $641,366,000 after buying an additional 514,698 shares during the period. Van Berkom & Associates Inc. lifted its holdings in Maximus by 22.3% during the third quarter. Van Berkom & Associates Inc. now owns 1,124,238 shares of the health services provider’s stock valued at $83,958,000 after purchasing an additional 204,796 shares during the last quarter. Assenagon Asset Management S.A. purchased a new stake in Maximus during the third quarter valued at about $13,451,000. SG Capital Management LLC purchased a new stake in Maximus during the third quarter valued at about $5,951,000. Finally, Envestnet Asset Management Inc. lifted its holdings in Maximus by 96.9% during the third quarter. Envestnet Asset Management Inc. now owns 105,752 shares of the health services provider’s stock valued at $7,898,000 after purchasing an additional 52,051 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on MMS shares. Raymond James downgraded shares of Maximus from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 3rd. StockNews.com raised shares of Maximus from a “hold” rating to a “buy” rating in a report on Thursday, February 8th.

Maximus Trading Down 0.2 %

Shares of Maximus stock opened at $80.43 on Friday. Maximus, Inc. has a 12-month low of $72.39 and a 12-month high of $89.69. The company has a market cap of $4.91 billion, a price-to-earnings ratio of 26.63 and a beta of 0.72. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.71. The company’s 50-day moving average price is $82.46 and its 200-day moving average price is $81.32.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Wednesday, February 7th. The health services provider reported $1.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.06. Maximus had a net margin of 3.73% and a return on equity of 15.68%. The firm had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same period in the prior year, the firm posted $0.94 earnings per share. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. On average, equities analysts expect that Maximus, Inc. will post 5.42 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date is Tuesday, May 14th. Maximus’s payout ratio is 39.74%.

Insider Transactions at Maximus

In related news, CFO David Mutryn sold 8,000 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $83.95, for a total value of $671,600.00. Following the sale, the chief financial officer now directly owns 5,124 shares of the company’s stock, valued at $430,159.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.40% of the company’s stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.